BioCentury
ARTICLE | Clinical News

Anidulafungin infectious data

November 8, 2004 8:00 AM UTC

In an open label, US Phase II trial in 19 patients, Anidulafungin led to clinical responses in 94% of oropharyngeal and 92% of esophageal candidiasis patients. Data were presented at the Interscience ...